Hereditary Persistence of Fetal Hemoglobin Caused by Single Nucleotide Promoter Mutations in Sickle Cell Trait and Hb SC Disease

被引:6
|
作者
Akinbami, Anthony O. [1 ]
Campbell, Andrew D. [2 ]
Han, Zeqiu J. [3 ]
Luo, Hong-Yuan [1 ]
Chui, David H. K. [1 ]
Steinberg, Martin H. [1 ]
机构
[1] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA
[2] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA
[3] Quest Diagnost Nichols Inst, Chantilly, VA USA
关键词
Globin gene expression; globin genes; Hb F; sickle cell trait; PATHOGENESIS;
D O I
10.3109/03630269.2015.1080725
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hereditary persistence of fetal hemoglobin (HPFH) can be caused by point mutations in the -globin gene promoters. We report three rare cases: a child compound heterozygous for Hb S (HBB: c.20A>T) and HPFH with a novel point mutation in the (A)-globin gene promoter who had 42.0% Hb S, 17.0% Hb A and 38.0% Hb F; a man with Hb SC (HBB: c.19G>A) disease and a point mutation in the (G)-globin gene promoter who had 54.0% Hb S, 18.0% Hb C and 25.0% Hb F; a child heterozygous for Hb S and HPFH due to mutations in both the (A)- and (G)-globin gene promoters in cis [(GA)((+)) HPFH], with 67.0% Hb A, 6.5% Hb S and 25.0% Hb F.
引用
收藏
页码:64 / 65
页数:2
相关论文
共 31 条
  • [21] HETEROCELLULAR HEREDITARY PERSISTENT FETAL HEMOGLOBIN (HHPFH) OCCURRING IN SICKLE TRAIT (AS) PARENTS NOT CONSISTENTLY LINKED TO THE BETA-S (BETA-S) GENE IN OFFSPRING WITH HOMOZYGOUS SICKLE-CELL DISEASE (SS) OR TRAIT
    ABSHIRE, TC
    ROLOFF, JS
    WALKER, L
    SELTZER, WK
    JACKSON, T
    MCCABE, ERB
    GITHENS, JH
    CLINICAL RESEARCH, 1987, 35 (01): : A210 - A210
  • [22] POSTNATAL DECLINE OF FETAL HEMOGLOBIN IN HOMOZYGOUS SICKLE-CELL DISEASE - RELATIONSHIP TO PARENTAL HB-F LEVELS
    MASON, KP
    GRANDISON, Y
    HAYES, RJ
    SERJEANT, BE
    SERJEANT, GR
    VAIDYA, S
    WOOD, WG
    BRITISH JOURNAL OF HAEMATOLOGY, 1982, 52 (03) : 455 - 463
  • [23] SAR1a promoter polymorphisms are not associated with fetal hemoglobin in patients with sickle cell disease from Cameroon
    Pule G.D.
    Bitoungui V.J.N.
    Chemegni B.C.
    Kengne A.P.
    Wonkam A.
    BMC Research Notes, 10 (1)
  • [24] NUCLEAR PROTEINS THAT BIND THE HUMAN GAMMA-GLOBIN GENE PROMOTER - ALTERATIONS IN BINDING PRODUCED BY POINT MUTATIONS ASSOCIATED WITH HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN
    GUMUCIO, DL
    ROOD, KL
    GRAY, TA
    RIORDAN, MF
    SARTOR, CI
    COLLINS, FS
    MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (12) : 5310 - 5322
  • [25] Prevention of Exercise-Related Death Unexplained by Preexisting Disease (EDU) Associated with Sickle Cell Trait (SCT) without Hemoglobin (Hb) Screening or Hb Specific Management
    Kark, John A.
    Labotka, Richard J.
    Gardner, John W.
    Ward, Frank T.
    BLOOD, 2010, 116 (21) : 416 - 417
  • [26] Gγ-196 C→T, Aγ-201 C→T:: Two novel mutations in the promoter region of the γ-globin genes associated with nondeletional hereditary persistence of fetal hemoglobin in Greece
    Tasiopouiou, Magdalini
    Boussiou, Marina
    Sinopouiou, Kilo
    Moraitis, George
    Loutradi-AnagnoStOU, Aphrodite
    Karababa, Photini
    BLOOD CELLS MOLECULES AND DISEASES, 2008, 40 (03) : 320 - 322
  • [27] CRISPR-Cas9 Genome Editing of Human CD34+Cells at Gamma-globin Promoter to Induce Fetal Hemoglobin as Sickle Cell Disease Therapy
    Katta, Varun
    O'Keefe, Kiera
    Lazzarotto, Cicera R.
    Mayuranathan, Thiyagaraj
    Yen, Jonathan
    Lee, GaHyun
    Li, Yichao
    Uchida, Naoya
    Pruett-Miller, Shondra M.
    Tisdale, John
    Sharma, Akshay
    Weiss, Mitchell J.
    Tsai, Shengdar Q.
    MOLECULAR THERAPY, 2021, 29 (04) : 9 - 9
  • [28] Identification of Small Molecules That Induce Therapeutic Levels of Fetal Hemoglobin for Treatment of Sickle Cell Disease By Pairing Machine Learning with High-Resolution Single Cell RNA Sequencing Maps of Adult and Fetal Human Erythropoiesis
    Cortes, Mauricio
    Monti, Anthony J.
    Sun, Sunny
    Lynch, Orna
    Xia, Youli
    Lin, Sarah
    Malamas, Michael
    Steelman, Scott
    Moorthy, Sriram Krishna
    Stewart, Morag
    Tozzo, Effie
    BLOOD, 2021, 138
  • [29] Homozygous Deletion Alpha-Thalassemia and Hereditary Persistence of Fetal Hemoglobin, Two Genetic Factors Predictive the Reduction of Morbidity and Mortality During Pregnancy in Sickle Cell Patients. A Report from the Democratic Republic of Congo
    Mikobi, Tite Minga
    Lukusa, Prosper Tshilobo
    Muamba, Jean-Marie Mbuyi
    Rhama, Tozin
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2019, 11
  • [30] Effects of BCL11A shmiR-Induced Post-Transcriptional Silencing on Distributions of Fetal Hemoglobin and Hemoglobin Polymer Inhibition in Single Red Blood Cells in Sickle Cell Disease Gene Therapy
    Hebert, Nicolas
    De Souza, Daniel C.
    Esrick, Erica B.
    Di Caprio, Giuseppe
    Ciuculescu, M. Felicia
    Audureau, Etienne
    Morris, Emily
    Armant, Myriam
    Goncalves, Bronner P.
    Schonbrun, Ethan
    McCabe, Amanda
    Liu, Donghui
    Williams, Dillon
    Archer, Natasha M.
    Brendel, Christian
    Wood, David K.
    Bartolucci, Pablo
    Higgins, John M.
    Williams, David A.
    MOLECULAR THERAPY, 2022, 30 (04) : 368 - 369